WUHAN KEQIAN BIOLOGY CO LTD revenue for the last year amounted to 1.06 B CNY, the most of which — 973.90 M CNY — came from its highest performing source at the moment, Swine Vaccine, the year earlier bringing 937.43 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought WUHAN KEQIAN BIOLOGY CO LTD 1.06 B CNY, and the year before that — 1.00 B CNY.